With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells.

For market-watchers in the pharmaceutical industry, the question is what potential they have and where they could take the market. Kalorama Information has tackled that question in Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development. Kalorama analyst Alison Sahoo has built models to determine the best, moderate and worst case scenarios for the three key markets for stem cells:

• Stem Cell Therapeutics (Transplantation)
• Cord Blood Banking and
• Drug development

This report breaks down forecasted revenues and procedure volumes for stem cell technologies for these segments in the following disease areas:

• Cardiovascular disease
• Lung disease
• Arthritis
• Incontinence
• Osteoporosis
• Diabetes
• Cancer
• Orthopedics
• Infertility
• Alzheimer’s disease
• Burns (severe)
• Lupus
• Parkinson’s disease
• Liver failure
• Multiple sclerosis
• Critical limb ischemia
• Crohn's disease
• Sickle cell disease
• Multiple myeloma
• NH lymphoma
• Leukemia

Ths report is the result of exclusive interviews with executives in the stem cell industry, a review of medical and company literature, government databases and publications. As part of this comprehensive analysis of stem cell markets, the following companies were profiled:

• Aastrom Biosciences
• Advanced Cell Technologies
• Brainstorm Cell Therapeutics
• Celegene
• Cord Blood America
• Cord Blood Registry
• Cryo-Cell International
• ES Cell International
• Geron
• Harvest Technologies
• Invitrogen
• Medistem
• Neostem
• Opexa Therapeutics
• Osiris Therapeutics
• Plureon
• Regenetech
• Revivicor
• Stem Cell Sciences
• StemLifeLine
• ThermoGenesis
• VetCell Bioscience
• ViaCell

License Note: Kalorama Information's listed default price on its information products reflects a single user license only. Purchasing a departmental license (up to 10 users at one location) or a global site license (entire company) permits multiple individuals in the company to benefit from this resource.

Related Reports:

The Worldwide Market for Cancer Diagnostics, 4th Edition
Apr 1, 2010 - KLI2504623 - $4,200.00

The Global Market for Medical Devices
Mar 1, 2010 - KLI2592223 - $1,500.00

2009 Worldwide Diagnostics Market Research Bundle
Oct 1, 2009 - KLI2401913 - $5,995.00

The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)
Oct 1, 2009 - KLI2435380 - $3,500.00

Implant-Based Dental Reconstruction: World Dental Implant and Bone Graft Market, 3rd Edition
Sep 1, 2009 - KLI2284095 - $3,500.00

Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems
Sep 1, 2009 - KLI2422083 - $2,995.00

The World Market for Biosimilars and the Potential for US Follow-on Biologics
Aug 1, 2009 - KLI2402283 - $3,700.00

Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Jun 1, 2009 - KLI2155319 - $3,995.00

The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition
May 1, 2009 - KLI2218043 - $3,995.00

Worldwide Wound Care: Total Market Coverage (Vols. I-III: Skin Ulcers, Burns, Surgical and Trauma Wounds), 4th Edition
May 1, 2009 - KLI2123150 - $3,995.00